Polivy Market Report 2026
Download Free Sample Buy Now
Polivy Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Polivy Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Polivy Market Overview

• The Polivy market growth in the historic period has been driven by increasing incidence of diffuse large b-cell lymphoma, advancements in monoclonal antibody development

• Market expansion is supported by increasing demand for personalized oncology drugs, rising investments in adc research pipelines

• Growth Driver: Growing Incidence Of Diffuse Large B-Cell Lymphoma Boosts Demand For Polivy

• Market Trend: Adoption of First-Line Antibody-Drug Conjugate Combinations in Polivy Market to Improve DLBCL Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Polivy Market?

Polivy (polatuzumab vedotin) is an antibody-drug conjugate used for the treatment of diffuse large B-cell lymphoma, which is a type of non-Hodgkin lymphoma. It is specifically indicated for adult patients with relapsed or refractory diffuse large B-cell lymphoma after they have undergone at least two prior therapies. Additionally, it can be used as a first-line treatment in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone for patients with moderate- to high-risk diffuse large B-cell lymphoma.

The main indications of polivy are previously untreated diffuse large b-cell lymphoma, relapsed or refractory diffuse large b-cell lymphoma. Previously untreated diffuse large B-cell lymphoma is a form of cancer affecting white blood cells that have not received any prior treatment. It is typically aggressive and requires prompt medical intervention. Polivy is used as part of combination therapy to address this condition effectively. It is dose in the form of injectable solutions and distributed through various channels such as direct sales, pharmaceutical wholesalers, and online pharmacies.

Polivy Market Global Report 2026 Market Report bar graph

What Is The Polivy Market Size and Share 2026?

The growth in the historic period can be attributed to increasing incidence of diffuse large b-cell lymphoma, advancements in monoclonal antibody development, expansion of oncology treatment centers, rising adoption of targeted cancer therapies, improved diagnostic capabilities.

What Is The Polivy Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for personalized oncology drugs, rising investments in adc research pipelines, expansion of first-line combination therapies, growing focus on treatment-resistant lymphomas, increasing regulatory approvals for targeted biologics. Major trends in the forecast period include increasing adoption of antibody-drug conjugates, rising use in targeted lymphoma therapies, growing integration with combination chemotherapy regimens, expansion of precision oncology treatments, enhanced focus on cd79b-targeted drugs.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Polivy Market Segmentation

1) By Indication: Previously Untreated Diffuse Large B-Cell Lymphoma, Relapsed Or Refractory Diffuse Large B-Cell Lymphoma

2) By Dosage Form: Injectable Solution

3) By Distribution Channel: Direct Sales, Pharmaceutical Wholesalers, Online Pharmacies

What Are The Drivers Of The Polivy Market?

The increasing incidence of diffuse large B-cell lymphoma is expected to propel the growth of the polivy market going forward. Diffuse large B-cell lymphoma (DLBCL), the most prevalent type of non-hodgkin lymphoma (NHL), is classified as a highly aggressive blood cancer that originates from B-lymphocytes, which are white blood cells essential for the immune system's function of producing antibodies to combat infections. The increasing incidence of diffuse large B-cell lymphoma can be attributed to several factors, including an aging population, rising rates of immunosuppression due to conditions such as HIV/AIDS and organ transplants, and environmental exposures that contribute to the disease's etiology. Polivy is used in combination with chemotherapy to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in patients who have received prior treatments. For instance, in July 2024, according to a report published by the Royal College of Pathologists, a UK-based professional membership organization, each year in the UK, approximately 5,500 individuals are diagnosed with diffuse large B-cell lymphoma (DLBCL), which is a highly aggressive form of non-Hodgkin lymphoma. About 30% of these patients will experience refractory disease or relapse shortly after their initial treatment. Therefore, the increasing incidence of diffuse large B-cell lymphoma is driving the growth of the polivy industry.

The rising number of oncology procedures is expected to propel the growth of the polivy market going forward. Oncology procedures refer to medical tests, treatments, and interventions performed to diagnose, manage, and treat various types of cancer. Oncology procedures are increasing as more healthcare providers and patients prioritize early cancer detection and access to effective targeted therapies. Polivy plays a crucial role in the rising number of oncology procedures by offering targeted therapy that improves outcomes and expands treatment options for cancer patients. For instance, in February 2024, according to the World Health Organization, a US-based United Nations agency, reported that over 35 million new cancer cases are predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising number of oncology procedures is driving the growth of the polivy industry.

Key Players In The Global Polivy Market

Major companies operating in the polivy market are F. Hoffmann-La Roche Ltd (Genentech Inc.)

Global Polivy Market Trends and Insights

Major companies operating in the polivy market are focusing on developing innovative regimens, such as first-line antibody-drug conjugate (ADC) combinations, to better target aggressive B-cell lymphomas and improve patient outcomes. A first-line ADC combination integrates a monoclonal antibody that selectively binds to tumor-specific proteins with a cytotoxic payload, enabling highly targeted therapy, unlike conventional chemotherapy, which affects both cancerous and healthy cells. For instance, in April 2023, Genentech, a U.S.-based biotechnology company, received FDA approval for Polivy (polatuzumab vedotin-piiq) in combination with R-CHP (rituximab, cyclophosphamide, doxorubicin, prednisone) for previously untreated diffuse large B-cell lymphoma (DLBCL) in adults. Polivy is a first-in-class anti-CD79b ADC developed using Seagen’s linker-payload technology: the antibody targets the CD79b protein on B-cells, the conjugated payload (vedotin) is a potent microtubule-disrupting agent, and upon binding the drug is internalized into the cancer cell where the cytotoxic agent is released to induce cell death. Its unique features include high specificity toward malignant B-cells, a more favorable safety profile compared to systemic chemotherapy, and a demonstrated 27% reduction in risk of progression or death versus standard R-CHOP in the pivotal POLARIX study. This combination is now poised to transform first-line treatment in DLBCL, potentially reducing relapse rates and alleviating long-term patient burden.

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the polivy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Polivy Market?

The polivy market consists of sales of polivy (polatuzumab vedotin) injections in 30 mg and 140 mg vials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Polivy Market Report 2026?

The polivy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the polivy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Polivy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Indication, Dosage Form, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled F. Hoffmann-La Roche Ltd (Genentech Inc.)
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Polivy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Polivy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Polivy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Polivy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Antibody-Drug Conjugates

4.2.2 Rising Use In Targeted Lymphoma Therapies

4.2.3 Growing Integration With Combination Chemotherapy Regimens

4.2.4 Expansion Of Precision Oncology Treatments

4.2.5 Enhanced Focus On Cd79B-Targeted Drugs

5. Polivy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Clinics

5.3 Cancer Treatment Centers

5.4 Specialty Pharmacies

5.5 Ambulatory Care Centers

6. Polivy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Polivy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Polivy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Polivy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Polivy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Polivy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Polivy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Polivy Market Segmentation

9.1. Global Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Previously Untreated Diffuse Large B-Cell Lymphoma, Relapsed Or Refractory Diffuse Large B-Cell Lymphoma

9.2. Global Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable Solution

9.3. Global Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Direct Sales, Pharmaceutical Wholesalers, Online Pharmacies

10. Polivy Market Regional And Country Analysis

10.1. Global Polivy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Polivy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Polivy Market

11.1. Asia-Pacific Polivy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Polivy Market

12.1. China Polivy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Polivy Market

13.1. India Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Polivy Market

14.1. Japan Polivy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Polivy Market

15.1. Australia Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Polivy Market

16.1. South Korea Polivy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Polivy Market

17.1. Western Europe Polivy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Polivy Market

18.1. UK Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Polivy Market

19.1. Germany Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Polivy Market

20.1. France Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Polivy Market

21.1. Eastern Europe Polivy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Polivy Market

22.1. North America Polivy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Polivy Market

23.1. USA Polivy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Polivy Market

24.1. Canada Polivy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Polivy Market

25.1. South America Polivy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Polivy Market

26.1. Middle East Polivy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Polivy Market

27.1. Africa Polivy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Polivy Market, Segmentation By Indication, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Polivy Market Regulatory and Investment Landscape

29. Polivy Market Competitive Landscape And Company Profiles

29.1. Polivy Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Polivy Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Polivy Market Company Profiles

29.3.1. F. Hoffmann-La Roche Ltd (Genentech Inc.) Overview, Products and Services, Strategy and Financial Analysis

30. Global Polivy Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Polivy Market

32. Polivy Market High Potential Countries, Segments and Strategies

32.1 Polivy Market In 2030 - Countries Offering Most New Opportunities

32.2 Polivy Market In 2030 - Segments Offering Most New Opportunities

32.3 Polivy Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Polivy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Polivy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Polivy Market, Supply Chain Analysis
  • Table 4: Global Polivy Market, Major Raw Material Providers
  • Table 5: Global Polivy Market, Major Resource Providers
  • Table 6: Global Polivy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Polivy Market, Major Distributors And Channel Partners
  • Table 8: Global Polivy Market, Key Technologies & Future Trends
  • Table 9: Global Polivy Market, Major Trends
  • Table 10: Global Polivy Market, Major End Users
  • Table 11: Global Polivy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Polivy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Polivy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Polivy Market - TAM, US$ Billion, 2025
  • Table 15: Global Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Polivy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Polivy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Asia-Pacific, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: China, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: India, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Japan, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Australia, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: South Korea, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Western Europe, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: UK, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Germany, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: France, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Eastern Europe, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: North America, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: USA, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Canada, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: South America, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Middle East, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Africa, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Global Polivy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 72: Global Polivy Market - Company Scoring Matrix
  • Table 73: F. Hoffmann-La Roche Ltd (Genentech Inc.) Financial Performance
  • Table 74: Global Polivy Market, Competitive Benchmarking (In USD Billions)
  • Table 75: Global Polivy Market, Competitive Dashboard
  • Table 76: Global Polivy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 77: Global, Polivy Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 78: Global, Polivy Market Size Gain ($ Billion), Segmentation By Dosage Form, 2025 – 2030
  • Table 79: Global, Polivy Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Polivy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Polivy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Polivy Market, Supply Chain Analysis
  • Figure 4: Global Polivy Market, Major Raw Material Providers
  • Figure 5: Global Polivy Market, Major Resource Providers
  • Figure 6: Global Polivy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Polivy Market, Major Distributors And Channel Partners
  • Figure 8: Global Polivy Market, Key Technologies & Future Trends
  • Figure 9: Global Polivy Market, Major Trends
  • Figure 10: Global Polivy Market, Major End Users
  • Figure 11: Global Polivy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Polivy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Polivy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Polivy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Polivy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Polivy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Asia-Pacific, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: China, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: India, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Japan, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Australia, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: South Korea, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Western Europe, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: UK, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Germany, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: France, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Eastern Europe, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: North America, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: USA, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Canada, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: South America, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Middle East, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Africa, Polivy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Polivy Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Polivy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Global Polivy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 72: Global Polivy Market - Company Scoring Matrix
  • Figure 73: F. Hoffmann-La Roche Ltd (Genentech Inc.) Financial Performance
  • Figure 74: Global Polivy Market, Competitive Benchmarking (In USD Billions)
  • Figure 75: Global Polivy Market, Competitive Dashboard
  • Figure 76: Global Polivy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 77: Global, Polivy Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 78: Global, Polivy Market Size Gain ($ Billion), Segmentation By Dosage Form, 2025 – 2030
  • Figure 79: Global, Polivy Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Hypermarkets Global Market Report 2024 – By Ownership (Retail Chain, Independent Retailer), By Marketing Channel (Traditional Marketing Channel (Offline), Online Channel), By Application (Consumer Electronics, Furniture,...

Geomarketing Market Report 2026 - Global Outlook – By Solution (Software, Service), By Deployment Mode (Cloud, On-Premises), By Location (Indoor, Outdoor), By Verticals (Retail And E-Commerce, Healthcare And Life Science...

Investments Market Report 2026 - Global Outlook – By Type (Wealth Management, Securities Brokerage And Stock Exchange Services, Investment Banking), By Mode (Online, Offline), By End User (B2B, B2C) – Market Size, Trends...

Market Research Services Market Report 2026 - Global Outlook – By Type (Marketing Research And Analysis Services, Public Opinion And Election Polling), By Research Methodology (Qualitative Research, Quantitative Research...

Sustainable Finance Market Report 2026 - Global Outlook – By Investment Type (Equity, Fixed Income, Mixed Allocation, Other Investment Types), By Transaction Type (Green Bond, Social Bond, Mixed-Sustainability Bond, Envi...

Renewable Energy Investment Market Report 2026 - Global Outlook – By Type ( Solar Energy, Wind Energy, Hydro Energy, Biomass Energy, Ocean Energy), By Offerings ( Services, Platform), By Organization Type ( Private Equit...

Data Lake Market Report 2026 - Global Outlook – By Type (Solution, Services), By Deployment (On-Premise, Cloud), By Organization Size (Large Enterprises, Small And Medium-Sized Enterprises (SMEs)), By Vertical (Informati...

Trade Finance Market Report 2026 - Global Outlook – By Type (Supply Chain Finance, Structured Trade Finance, Traditional Trade Finance), By Service Provider (Banks, Financial Institutions, Trading Houses, Other Services)...

Frequently Asked Questions

The Polivy market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Polivy market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Polivy market Include, F. Hoffmann-La Roche Ltd (Genentech Inc.) .

Major trend in this market includes: Adoption of First-Line Antibody-Drug Conjugate Combinations in Polivy Market to Improve DLBCL Treatment. For further insights on this market. request a sample here

North America was the largest region in the polivy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polivy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us